Bausch Health Cos., Inc.
(Toronto Stock Exchange : BHC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. 0.37%29.8414.1%$175.58m
AMRNAmarin Corp. Plc 0.10%21.091.7%$169.55m
AXSMAxsome Therapeutics, Inc. -0.93%87.911.9%$98.88m
SAVACassava Sciences, Inc. -0.51%7.850.0%$89.31m
BHCBausch Health Cos., Inc. 0.37%29.840.0%$79.02m
GWPHGW Pharmaceuticals Plc -0.79%120.076.2%$72.66m
JAZZJazz Pharmaceuticals Plc 0.67%151.362.3%$64.84m
SAGESAGE Therapeutics, Inc. 1.38%74.288.6%$62.75m
PRGOPerrigo Co. Plc 0.33%60.036.8%$60.75m
ICPTIntercept Pharmaceuticals, Inc. 0.56%101.3016.9%$59.44m
HZNPHorizon Therapeutics Plc 0.71%38.526.6%$55.22m
ENDPEndo International Plc -1.25%6.308.8%$43.31m
MNKMallinckrodt Plc -3.15%5.8520.9%$42.66m
ICLRICON plc -0.41%173.544.2%$40.58m
PTLAPortola Pharmaceuticals, Inc. 0.36%14.086.7%$35.61m

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.